These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
161 related articles for article (PubMed ID: 18972907)
1. Effectiveness of intravenous bisphosphonate in treatment of giant cell tumor: a case report and review of the literature. Arpornchayanon O; Leerapun T J Med Assoc Thai; 2008 Oct; 91(10):1609-12. PubMed ID: 18972907 [TBL] [Abstract][Full Text] [Related]
2. Bisphosphonate therapy is effective in the treatment of sacral giant cell tumor. Chaudhary P; Khadim H; Gajra A; Damron T; Shah C Onkologie; 2011; 34(12):702-4. PubMed ID: 22156450 [TBL] [Abstract][Full Text] [Related]
3. Adjuvant treatment with zoledronic acid after extensive curettage for giant cell tumours of bone. Gouin F; Rochwerger AR; Di Marco A; Rosset P; Bonnevialle P; Fiorenza F; Anract P Eur J Cancer; 2014 Sep; 50(14):2425-31. PubMed ID: 25088085 [TBL] [Abstract][Full Text] [Related]
4. Zoledronic acid-loaded bone cement as a local adjuvant therapy for giant cell tumor of the sacrum after intralesional curettage. Chen KH; Wu PK; Chen CF; Chen WM Eur Spine J; 2015 Oct; 24(10):2182-8. PubMed ID: 25940568 [TBL] [Abstract][Full Text] [Related]
5. [The analysis of the treatment of giant cell tumor of the pelvis and sacrum]. Guo W; Tang XD; Li X; Ji T; Sun X Zhonghua Wai Ke Za Zhi; 2008 Apr; 46(7):501-5. PubMed ID: 18785558 [TBL] [Abstract][Full Text] [Related]
6. Locally administered zoledronic Acid therapy for giant cell tumor of bone. Nishisho T; Hanaoka N; Endo K; Takahashi M; Yasui N Orthopedics; 2011 Jul; 34(7):e312-5. PubMed ID: 21717996 [TBL] [Abstract][Full Text] [Related]
7. Regression of giant cell tumor of the cervical spine with bisphosphonate as single therapy. Gille O; Oliveira Bde A; Guerin P; Lepreux S; Richez C; Vital JM Spine (Phila Pa 1976); 2012 Mar; 37(6):E396-9. PubMed ID: 22076646 [TBL] [Abstract][Full Text] [Related]
8. [Case analysis on treatment and recurrence of giant cell tumor of bone]. Zhang Z; Zhu B; Sun T Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2006 Oct; 20(10):1007-10. PubMed ID: 17140075 [TBL] [Abstract][Full Text] [Related]
9. Bisphosphonates induce apoptosis of stromal tumor cells in giant cell tumor of bone. Cheng YY; Huang L; Lee KM; Xu JK; Zheng MH; Kumta SM Calcif Tissue Int; 2004 Jul; 75(1):71-7. PubMed ID: 15037971 [TBL] [Abstract][Full Text] [Related]
10. Local administration of zoledronic acid for giant cell tumor of bone. Nishisho T; Hanaoka N; Miyagi R; Sakai T; Toki S; Takahashi M; Kenji E; Yasui N; Sairyo K Orthopedics; 2015 Jan; 38(1):e25-30. PubMed ID: 25611416 [TBL] [Abstract][Full Text] [Related]
11. [The choice strategy of surgical treatment for giant cell tumor close to the knee]. Yang ZM; Tao HM; Yang DS; Ye ZM; Li WX Zhonghua Wai Ke Za Zhi; 2006 Dec; 44(24):1693-8. PubMed ID: 17359718 [TBL] [Abstract][Full Text] [Related]
12. Decision making in primary sacral tumors. Puri A; Agarwal MG; Shah M; Srinivas CH; Shukla PJ; Shrikhande SV; Jambhekar NA Spine J; 2009 May; 9(5):396-403. PubMed ID: 19059810 [TBL] [Abstract][Full Text] [Related]
13. Giant cell tumour of a phalanx in the foot: a case report. Dridi M; Annabi H; Ben Ghozlen R; Abdelkefi M; Trabelsi M Acta Orthop Belg; 2008 Apr; 74(2):273-5. PubMed ID: 18564489 [TBL] [Abstract][Full Text] [Related]
14. Giant cell tumor of the thoracic spine: case report and review of the literature. Refai D; Dunn GP; Santiago P Surg Neurol; 2009 Feb; 71(2):228-33; discussion 233. PubMed ID: 18207522 [TBL] [Abstract][Full Text] [Related]
15. Giant cell tumour of the sacrum: function-preserving surgery with extended curettage and ilio-lumbar fusion. Lakdawala RH; Ahmad T; Enam SA J Ayub Med Coll Abbottabad; 2013; 25(3-4):94-7. PubMed ID: 25226752 [TBL] [Abstract][Full Text] [Related]
16. Denosumab in giant cell tumour of bone in the pelvis and sacrum: Long-term therapy or bone resection? Sambri A; Medellin MR; Errani C; Campanacci L; Fujiwara T; Donati D; Parry M; Grimer R J Orthop Sci; 2020 May; 25(3):513-519. PubMed ID: 31155442 [TBL] [Abstract][Full Text] [Related]
17. Clinical and immunological evaluation of zoledronate-activated Vgamma9gammadelta T-cell-based immunotherapy for patients with multiple myeloma. Abe Y; Muto M; Nieda M; Nakagawa Y; Nicol A; Kaneko T; Goto S; Yokokawa K; Suzuki K Exp Hematol; 2009 Aug; 37(8):956-68. PubMed ID: 19409955 [TBL] [Abstract][Full Text] [Related]
18. [Giant-cell tumor of the sacrum: an analysis of 10 cases]. Luo XZ Zhonghua Wai Ke Za Zhi; 1990 May; 28(5):272-3, 317. PubMed ID: 2086095 [TBL] [Abstract][Full Text] [Related]
19. Biennial [corrected] IV zoledronic acid (Reclast) for prevention of osteoporosis. Med Lett Drugs Ther; 2009 Jun; 51(1315):49. PubMed ID: 19556940 [No Abstract] [Full Text] [Related]
20. Cytochemical and ultrastructural changes in the osteoclast-like giant cells of giant cell tumor of bone following bisphosphonate administration. Cheng YY; Huang L; Kumta SM; Lee KM; Lai FM; Tam JS Ultrastruct Pathol; 2003; 27(6):385-91. PubMed ID: 14660277 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]